S&P 500 4,967.23

DOW 37,986.40

QQQ 414.65

How major US stock indexes fared Friday, 4/19/2024

Tiny Biotech Stock Wins $75 Billion Patent (Ad)

Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week

American Express profits jump 34%, helped by jump in new customers, higher spending

The #1 Crypto for 2024 (Ad)

American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024

Intuitive Surgical Stock Can Trend Much Higher This Year

Secret Bull Market Starts in This Unusual Sector (Ad)

3 Magnificent Seven Stocks Outperforming the Rest

Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

S&P 500 4,967.23

DOW 37,986.40

QQQ 414.65

How major US stock indexes fared Friday, 4/19/2024

Tiny Biotech Stock Wins $75 Billion Patent (Ad)

Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week

American Express profits jump 34%, helped by jump in new customers, higher spending

The #1 Crypto for 2024 (Ad)

American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024

Intuitive Surgical Stock Can Trend Much Higher This Year

Secret Bull Market Starts in This Unusual Sector (Ad)

3 Magnificent Seven Stocks Outperforming the Rest

Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

S&P 500 4,967.23

DOW 37,986.40

QQQ 414.65

How major US stock indexes fared Friday, 4/19/2024

Tiny Biotech Stock Wins $75 Billion Patent (Ad)

Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week

American Express profits jump 34%, helped by jump in new customers, higher spending

The #1 Crypto for 2024 (Ad)

American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024

Intuitive Surgical Stock Can Trend Much Higher This Year

Secret Bull Market Starts in This Unusual Sector (Ad)

3 Magnificent Seven Stocks Outperforming the Rest

Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

S&P 500 4,967.23

DOW 37,986.40

QQQ 414.65

How major US stock indexes fared Friday, 4/19/2024

Tiny Biotech Stock Wins $75 Billion Patent (Ad)

Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week

American Express profits jump 34%, helped by jump in new customers, higher spending

The #1 Crypto for 2024 (Ad)

American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024

Intuitive Surgical Stock Can Trend Much Higher This Year

Secret Bull Market Starts in This Unusual Sector (Ad)

3 Magnificent Seven Stocks Outperforming the Rest

Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Free Trial

WallachBeth Capital Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: WallachBeth Capital
Rating: 2.7
Author: MarketBeat

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at WallachBeth Capital. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by WallachBeth Capital.

Company	Current Price	Rating Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price	Details
QURE uniQure	$4.67 -0.8%	12/6/2016	Target Lowered by	WallachBeth Capital	-	Buy	$27.00 -> $15.00	N/A	View details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 12/6/2016
IRWD Ironwood Pharmaceuticals	$7.92 +4.2%	9/27/2016	Target Raised by	WallachBeth Capital	-	Hold	$15.00 -> $17.00	N/A	View details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 9/27/2016
VTGN Vistagen Therapeutics	$4.76 +1.3%	7/7/2016	Initiated by	WallachBeth Capital	-	Buy	$510.00	N/A	View details for WallachBeth Capital rating of Vistagen Therapeutics (NASDAQ:VTGN) on 7/7/2016
ESPR Esperion Therapeutics	$1.95 +4.3%	7/5/2016	Downgraded by	WallachBeth Capital	-	Buy -> Hold	$35.00	N/A	View details for WallachBeth Capital rating of Esperion Therapeutics (NASDAQ:ESPR) on 7/5/2016
QURE uniQure	$4.67 -0.8%	6/15/2016	Target Lowered by	WallachBeth Capital	-	Buy	$60.00 -> $35.00	N/A	View details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 6/15/2016
QURE uniQure	$4.67 -0.8%	12/1/2015	Target Raised by	WallachBeth Capital	-	Buy	$33.00 -> $60.00	N/A	View details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 12/1/2015
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ESPR Esperion Therapeutics	$1.95 +4.3%	10/26/2015	Initiated by	WallachBeth Capital	-	Buy	$34.00	N/A	View details for WallachBeth Capital rating of Esperion Therapeutics (NASDAQ:ESPR) on 10/26/2015
QURE uniQure	$4.67 -0.8%	8/28/2015	Target Lowered by	WallachBeth Capital	-	Buy	$35.00 -> $33.00	N/A	View details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 8/28/2015
QURE uniQure	$4.67 -0.8%	8/7/2015	Initiated by	WallachBeth Capital	-	Buy	$35.00	N/A	View details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 8/7/2015
GMED Globus Medical	$50.37 -0.7%	3/2/2015	Target Raised by	WallachBeth Capital	-	Buy	$26.00 -> $30.00	N/A	View details for WallachBeth Capital rating of Globus Medical (NYSE:GMED) on 3/2/2015
IRWD Ironwood Pharmaceuticals	$7.92 +4.2%	2/13/2015	Target Raised by	WallachBeth Capital	-	Hold	$15.00 -> $17.00	N/A	View details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 2/13/2015
GMED Globus Medical	$50.37 -0.7%	8/6/2014	Upgraded by	WallachBeth Capital	-	Hold -> Buy	$27.00 -> $24.00	N/A	View details for WallachBeth Capital rating of Globus Medical (NYSE:GMED) on 8/6/2014
INGR Ingredion	$113.67 +1.2%	6/18/2014	Initiated by	WallachBeth Capital	-	Hold	$16.00	N/A	View details for WallachBeth Capital rating of Ingredion (NYSE:INGR) on 6/18/2014
IRWD Ironwood Pharmaceuticals	$7.92 +4.2%	6/18/2014	Initiated by	WallachBeth Capital	-	Hold	$16.00	N/A	View details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 6/18/2014
WB Weibo	$7.90 -2.0%	5/13/2014	Downgraded by	WallachBeth Capital	-	Buy -> Hold	$4.00 -> $2.50	N/A	View details for WallachBeth Capital rating of Weibo (NASDAQ:WB) on 5/13/2014
GMED Globus Medical	$50.37 -0.7%	2/27/2014	Downgraded by	WallachBeth Capital	-	Buy -> Hold	$23.00 -> $27.00	N/A	View details for WallachBeth Capital rating of Globus Medical (NYSE:GMED) on 2/27/2014
GMED Globus Medical	$50.37 -0.7%	5/17/2013	Initiated by	WallachBeth Capital	-	Buy	$19.00	N/A	View details for WallachBeth Capital rating of Globus Medical (NYSE:GMED) on 5/17/2013
PDCO Patterson Companies	$26.02 +2.2%	5/14/2013	Downgraded by	WallachBeth Capital	-	Buy -> Hold	$40.00	N/A	View details for WallachBeth Capital rating of Patterson Companies (NASDAQ:PDCO) on 5/14/2013
LIFE aTyr Pharma	$1.60 -1.2%	4/15/2013	Downgraded by	WallachBeth Capital	-	Buy -> Hold	$1,036.00 -> $1,064.00	N/A	View details for WallachBeth Capital rating of aTyr Pharma (NASDAQ:LIFE) on 4/15/2013
LH Laboratory Co. of America	$201.48 +1.0%	4/12/2013	Downgraded by	WallachBeth Capital	-	Buy -> Hold	$97.00	N/A	View details for WallachBeth Capital rating of Laboratory Co. of America (NYSE:LH) on 4/12/2013
TMO Thermo Fisher Scientific	$544.79 +0.6%	4/4/2013	Downgraded by	WallachBeth Capital	-	Buy -> Hold	$68.00 -> $76.00	N/A	View details for WallachBeth Capital rating of Thermo Fisher Scientific (NYSE:TMO) on 4/4/2013
BMY Bristol-Myers Squibb	$48.93 +1.3%	3/25/2013	Downgraded by	WallachBeth Capital	-	Buy -> Hold		N/A	View details for WallachBeth Capital rating of Bristol-Myers Squibb (NYSE:BMY) on 3/25/2013
UHS Universal Health Services	$157.39 +2.4%	3/4/2013	Downgraded by	WallachBeth Capital	-	Buy -> Hold	$61.00	N/A	View details for WallachBeth Capital rating of Universal Health Services (NYSE:UHS) on 3/4/2013
JAZZ Jazz Pharmaceuticals	$109.94 +0.6%	2/27/2013	Target Raised by	WallachBeth Capital	-	Buy	$63.00 -> $70.00	N/A	View details for WallachBeth Capital rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 2/27/2013
LIFE aTyr Pharma	$1.60 -1.2%	2/6/2013	Target Raised by	WallachBeth Capital	-	Buy	$1,036.00 -> $1,078.00	N/A	View details for WallachBeth Capital rating of aTyr Pharma (NASDAQ:LIFE) on 2/6/2013
HCA HCA Healthcare	$305.11 +2.7%	2/6/2013	Target Raised by	WallachBeth Capital	-	Hold	$31.00 -> $36.00	N/A	View details for WallachBeth Capital rating of HCA Healthcare (NYSE:HCA) on 2/6/2013
WAT Waters	$295.98 +0.6%	1/28/2013	Upgraded by	WallachBeth Capital	-	Hold -> Buy	$87.00 -> $103.00	N/A	View details for WallachBeth Capital rating of Waters (NYSE:WAT) on 1/28/2013
LIFE aTyr Pharma	$1.60 -1.2%	1/22/2013	Target Raised by	WallachBeth Capital	-	Buy	$798.00 -> $1,078.00	N/A	View details for WallachBeth Capital rating of aTyr Pharma (NASDAQ:LIFE) on 1/22/2013
IRWD Ironwood Pharmaceuticals	$7.92 +4.2%	1/16/2013	Target Raised by	WallachBeth Capital	-	Hold	$10.00 -> $13.00	N/A	View details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 1/16/2013
BMY Bristol-Myers Squibb	$48.93 +1.3%	1/8/2013	Target Raised by	WallachBeth Capital	-	Buy	$44.50 -> $49.50	N/A	View details for WallachBeth Capital rating of Bristol-Myers Squibb (NYSE:BMY) on 1/8/2013
IRWD Ironwood Pharmaceuticals	$7.92 +4.2%	12/18/2012	Initiated by	WallachBeth Capital	-	Hold		N/A	View details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 12/18/2012
LH Laboratory Co. of America	$201.48 +1.0%	11/13/2012	Upgraded by	WallachBeth Capital	-	Hold -> Buy	$91.00 -> $97.00	N/A	View details for WallachBeth Capital rating of Laboratory Co. of America (NYSE:LH) on 11/13/2012
ES Eversource Energy	$59.69 +1.2%	11/13/2012	Target Raised by	WallachBeth Capital	-	Hold	$3.50 -> $5.00	N/A	View details for WallachBeth Capital rating of Eversource Energy (NYSE:ES) on 11/13/2012
MYGN Myriad Genetics	$18.50 -0.1%	10/1/2012	Initiated by	WallachBeth Capital	-	Buy	$31.00	N/A	View details for WallachBeth Capital rating of Myriad Genetics (NASDAQ:MYGN) on 10/1/2012
PDCO Patterson Companies	$26.02 +2.2%	9/19/2012	Initiated by	WallachBeth Capital	-	Buy	$40.00	N/A	View details for WallachBeth Capital rating of Patterson Companies (NASDAQ:PDCO) on 9/19/2012
LIFE aTyr Pharma	$1.60 -1.2%	9/10/2012	Initiated by	WallachBeth Capital	-	Buy		N/A	View details for WallachBeth Capital rating of aTyr Pharma (NASDAQ:LIFE) on 9/10/2012
HSIC Henry Schein	$70.86 +1.3%	9/6/2012	Initiated by	WallachBeth Capital	-	Hold		N/A	View details for WallachBeth Capital rating of Henry Schein (NASDAQ:HSIC) on 9/6/2012
BMY Bristol-Myers Squibb	$48.93 +1.3%	9/4/2012	Initiated by	WallachBeth Capital	-	Buy	$41.00	N/A	View details for WallachBeth Capital rating of Bristol-Myers Squibb (NYSE:BMY) on 9/4/2012
MTD Mettler-Toledo International	$1,188.54 -0.3%	8/28/2012	Initiated by	WallachBeth Capital	-	Hold	$173.00	N/A	View details for WallachBeth Capital rating of Mettler-Toledo International (NYSE:MTD) on 8/28/2012
LH Laboratory Co. of America	$201.48 +1.0%	8/27/2012	Initiated by	WallachBeth Capital	-	Hold	$91.00	N/A	View details for WallachBeth Capital rating of Laboratory Co. of America (NYSE:LH) on 8/27/2012
Secret Bull Market Starts in This Unusual Sector (Ad) "We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. Click for my No. 1 investment, all free of charge, click here.
DGX Quest Diagnostics	$128.44 +2.0%	8/27/2012	Initiated by	WallachBeth Capital	-	Hold		N/A	View details for WallachBeth Capital rating of Quest Diagnostics (NYSE:DGX) on 8/27/2012
JAZZ Jazz Pharmaceuticals	$109.94 +0.6%	8/27/2012	Initiated by	WallachBeth Capital	-	Buy	$63.00	N/A	View details for WallachBeth Capital rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 8/27/2012

MarketBeat Community Rating for WallachBeth Capital

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		24,022 (Vote Outperform)
Underperform Votes:		20,752 (Vote Underperform)
Total Votes:		44,774

MarketBeat's community ratings are surveys of what our community members think about WallachBeth Capital and other research firms. Vote "Outperform" if you believe WallachBeth Capital's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WallachBeth Capital's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

WallachBeth Capital Analyst Recommendations & Stock Picks

MarketBeat Community Rating for WallachBeth Capital

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info